These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Does endotoxin accelerate rejection in a cardiac allograft model? Pirenne J; Médot M; Battafarano R; Benedetti E; Kim S; Dunn DL Transplant Proc; 1996 Oct; 28(5):2463-4. PubMed ID: 8907903 [No Abstract] [Full Text] [Related]
8. Chlorpromazine inhibits both the constitutive nitric oxide synthase and the induction of nitric oxide synthase after LPS challenge. Palacios M; Padron J; Glaria L; Rojas A; Delgado R; Knowles R; Moncada S Biochem Biophys Res Commun; 1993 Oct; 196(1):280-6. PubMed ID: 7692850 [TBL] [Abstract][Full Text] [Related]
9. Prevention of chronic rejection and graft arteriosclerosis by tolerance induction. Orloff MS; DeMara EM; Coppage ML; Leong N; Fallon MA; Sickel J; Zuo XJ; Prehn J; Jordan SC Transplantation; 1995 Jan; 59(2):282-8. PubMed ID: 7839452 [TBL] [Abstract][Full Text] [Related]
10. Myocytes isolated from rejecting transplanted rat hearts exhibit reduced basal shortening which is reversible by aminoguanidine. Ziolo MT; Dollinger SJ; Wahler GM J Mol Cell Cardiol; 1998 May; 30(5):1009-17. PubMed ID: 9618241 [TBL] [Abstract][Full Text] [Related]
11. Role of ICAM-1 in chronic rejection in the rat heart transplantation model. Hamano K; Ito H; Suzuki K; Shirasawa B; Gohra H; Katoh T; Fujimura Y; Tsuboi H; Esato K Transplant Proc; 1996 Jun; 28(3):1822. PubMed ID: 8658899 [No Abstract] [Full Text] [Related]
12. Modulation of inflammatory activation pathways in the Lewis-to-F-344 rat chronic cardiac rejection model. Russell ME; Hancock WW; Wallace AF; Wyner LR; Karnovsky MJ Transplant Proc; 1995 Jun; 27(3):2100-4. PubMed ID: 7792898 [No Abstract] [Full Text] [Related]
13. Expression of nitric oxide and inducible nitric oxide synthase in acute renal allograft rejection in the rat. Suzuki A; Kudoh S; Mori K; Takahashi N; Suzuki T Int J Urol; 2004 Oct; 11(10):837-44. PubMed ID: 15479287 [TBL] [Abstract][Full Text] [Related]
14. Evidence for recipient derived fibroblast recruitment and activation during the development of chronic cardiac allograft rejection. Wu GD; Tuan TL; Bowdish ME; Jin YS; Starnes VA; Cramer DV; Barr ML Transplantation; 2003 Aug; 76(3):609-14. PubMed ID: 12923453 [TBL] [Abstract][Full Text] [Related]
15. Comparison of rapamycin, RS 61443, cyclosporine, and low-dose heparin as treatment for transplant vasculopathy in a rat model of chronic allograft rejection. Schmid C; Heemann U; Azuma H; Tilney NL Transplant Proc; 1995 Feb; 27(1):438-9. PubMed ID: 7879053 [No Abstract] [Full Text] [Related]
17. Nitric oxide synthase activity in genetic hypertension. Malinski T; Kapturczak M; Dayharsh J; Bohr D Biochem Biophys Res Commun; 1993 Jul; 194(2):654-8. PubMed ID: 7688219 [TBL] [Abstract][Full Text] [Related]
18. The activity of inducible nitric oxide synthase in rejected skin xenografts is selectively inhibited by a factor produced by grafted cells. Holán V; Pindjáková J; Zajícová A; Krulová M; Zelezná B; Matousek P; Svoboda P Xenotransplantation; 2005 May; 12(3):227-34. PubMed ID: 15807773 [TBL] [Abstract][Full Text] [Related]
19. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. Worrall NK; Lazenby WD; Misko TP; Lin TS; Rodi CP; Manning PT; Tilton RG; Williamson JR; Ferguson TB J Exp Med; 1995 Jan; 181(1):63-70. PubMed ID: 7528779 [TBL] [Abstract][Full Text] [Related]